John Spritzler

4.1k citations
55 papers · 3.3k · h-index 29

Impact in

  • Virology top 0.2%
    • HIV Research and Treatment
  • Infectious Diseases top 1%
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

  • Virology 37
    • HIV Research and Treatment 37
  • Infectious Diseases 20
    • HIV/AIDS Research and Interventions 14
    • HIV/AIDS drug development and treatment 14
Co-authors
Alan Landay (25 shared papers)Michael M. Lederman (26 shared papers)Daniel R. Kuritzkes (15 shared papers)Harold A. Kessler (10 shared papers)Elizabeth Connick (9 shared papers)Lawrence Fox (14 shared papers)Richard B. Pollard (14 shared papers)Jeffrey M. Jacobson (9 shared papers)
Journals
The Journal of Infectious Diseases (18 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (11 papers)AIDS (5 papers)AIDS Research and Human Retroviruses (3 papers)Antiviral Research (2 papers)
Partner nations
United StatesCanadaJapan

In The Last Decade

John Spritzler

55 papers receiving 3.2k citations

Peers

John Spritzler
Comparison fields: 5 of 111
  • Virology 1.6k
  • Infectious Diseases 1.0k
  • Emergency Medicine 341
  • Immunology 766
  • Epidemiology 723
Replace P T Schellekens with:
P T Schellekens Netherlands
Alessandro Sinicco Italy
Hao Wu China
Deborah K. McMahon United States
Jason D. Barbour United States
M. Dietrich Germany
Maurice R.G. O’Gorman United States
Clyde S. Crumpacker United States
Patricia Barditch‐Crovo United States
C. McLaren United States
John Spritzler relative to P T Schellekens Netherlands P T Schellekens's profile →
Citations per field
00.5×2×3×4.1×
P T Schellekens · 1×
Citations per year

Countries citing papers authored by John Spritzler

Since Specialization
Citations

This map shows the geographic impact of John Spritzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Spritzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Spritzler more than expected).

Fields of papers citing papers by John Spritzler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Spritzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Spritzler. The network helps show where John Spritzler may publish in the future.

Co-authors

The 25 scholars most cited alongside John Spritzler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Spritzler Line = papers co-authored together John Spritzler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315
The Journal of Infectious Diseases ·Michael M. Lederman, Elizabeth Connick, Alan Landay, Daniel R. Kuritzkes, John Spritzler, Marty St. Clair, Brian L. Kotzin, L L Fox, Margo Heath Chiozzi, John M. Leonard, Franck Rousseau, Michael S. Wade, Joana D'Arc Roe, A. L. Sánchez Martinez, Harold A. Kessler
1998362
2
Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection
New England Journal of Medicine ·Jeffrey M. Jacobson, John S. Greenspan, John Spritzler, Nzeera Ketter, John L. Fahey, J. Brooks Jackson, Lawrence K. Fox, Miriam Chernoff, Albert W. Wu, Laurie A. MacPhail, Guillermo J. Vasquez, David A. Wohl
1997334
3
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
Blood ·Irini Sereti, Richard M. Dunham, John Spritzler, Evgenia Aga, Michael A. Proschan, Kathy Medvik, Catherine A. Battaglia, Alan Landay, Savita Pahwa, Margaret A. Fischl, David M. Asmuth, Allan R. Tenorio, John D. Altman, Lawrence Fox, Susan Moir, Angela Malaspina, Michel Morre, Renaud Buffet, Guido Silvestri, Michael M. Lederman
2009275
4
Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384
Clinical Infectious Diseases ·Gregory K. Robbins, John Spritzler, Ellen S. Chan, David M. Asmuth, Rajesh T. Gandhi, Benigno Rodríguez, Gail Skowron, Paul R. Skolnik, Robert W. Shafer, Richard B. Pollard
2009175
5
Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response
The Journal of Infectious Diseases ·Elizabeth Connick, Michael M. Lederman, Brian L. Kotzin, John Spritzler, Daniel R. Kuritzkes, Marty St. Clair, Anne Sevin, Lawrence Fox, Margo Heath Chiozzi, John M. Leonard, Franck Rousseau, Joana D'Arc Roe, Ana Martı́nez, Harold A. Kessler, Alan Landay
2000153
6
Thymic Size and Lymphocyte Restoration in Patients with Human Immunodeficiency Virus Infection after 48 Weeks of Zidovudine, Lamivudine, and Ritonavir Therapy
The Journal of Infectious Diseases ·Kimberly Y. Smith, Hernán Valdez, Alan Landay, John Spritzler, Harold A. Kessler, Elizabeth Connick, Daniel R. Kuritzkes, Barry H. Gross, Isaac R. Francis, Joseph M. McCune, M. M. Lederman, (unknown)
2000147
7
Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Rajesh T. Gandhi, John Spritzler, Ellen S. Chan, David M. Asmuth, Benigno Rodríguez, Thomas C. Merigan, Martin Hirsch, Robert W. Shafer, Gregory K. Robbins, Richard B. Pollard
2006135
8
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen
AIDS ·Hernán Valdez, Kimberly Y. Smith, Alan Landay, Elizabeth Connick, Daniel R. Kuritzkes, Harold A. Kessler, Lawrence Fox, John Spritzler, Joana D'Arc Roe, Miriam B. Lederman, Howard M. Lederman, Thomas G. Evans, Margo Heath‐Chiozzi, Michael M. Lederman
2000133
9
Age‐Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8+Cell Depletion, Reduced Expression of CD28 on CD8+Cells, and Reduced Thymic Volumes
The Journal of Infectious Diseases ·Robert C. Kalayjian, Alan Landay, Richard B. Pollard, Dennis D. Taub, Barry H. Gross, Isaac R. Francis, Anne Sevin, Minya Pu, John Spritzler, Miriam Chernoff, Ann Namkung, Lawrence Fox, A. L. Sánchez Martinez, Karen Waterman, Susan A. Fiscus, Beverly E. Sha, Debra Johnson, Stanley Slater, Frank Rousseau, Michael M. Lederman
2003132
10
Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection
Antimicrobial Agents and Chemotherapy ·Jeffrey M. Jacobson, Lawrence Feinman, Leonard Liebes, Nancy A. Ostrow, Victoria Koslowski, Alfonso J. Tobia, Bernard E. Cabana, Dong Hun Lee, John Spritzler, Alfred M. Prince
2001131
11
Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Numbers in Human Immunodeficiency Virus-Positive Adults
Clinical and Diagnostic Laboratory Immunology ·Carol Schnizlein‐Bick, John Spritzler, Cynthia L. Wilkening, Janet K.A. Nicholson, Maurice R.G. O’Gorman, (unknown)
2000104
12
Multisite Comparison of CD4 and CD8 T-Lymphocyte Counting by Single- versus Multiple-Platform Methodologies: Evaluation of Beckman Coulter Flow-Count Fluorospheres and the tetraONE System
Clinical and Diagnostic Laboratory Immunology ·Keith A. Reimann, Maurice R.G. O’Gorman, John Spritzler, Cynthia L. Wilkening, Daniel E. Sabath, Karen M. Helm, Donald E. Campbell, (unknown)
200088
13
Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1–Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular Restoration, and Virologic End Points
The Journal of Infectious Diseases ·Hulin Wu, Daniel R. Kuritzkes, Daniel McClernon, Harold A. Kessler, Elizabeth Connick, Alan Landay, Greg T. Spear, Margo Heath‐Chiozzi, Franck Rousseau, Lawrence Fox, John Spritzler, John M. Leonard, Michael M. Lederman
199988
14
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease
AIDS ·Lena Al‐Harthi, J N Siegel, John Spritzler, John C. Pottage, Michelle Agnoli, Alan Landay
200082
15
AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein
The Journal of Infectious Diseases ·Robert T. Schooley, John Spritzler, Hongying Wang, Michael M. Lederman, Diane V. Havlir, Daniel R. Kuritzkes, Richard B. Pollard, Cathy Battaglia, Michael Robertson, Devan V. Mehrotra, Danilo R. Casimiro, (unknown), Barbara Schock
201081
16
Evidence That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC‐HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068
The Journal of Infectious Diseases ·Jeffrey M. Jacobson, R. Pat Bucy, John Spritzler, Michael S. Saag, Joseph J. Eron, Robert W. Coombs, Rui Wang, Lawrence Fox, Victoria A. Johnson, Susan Cu‐Uvin, Susan E. Cohn, Donna Mildvan, Dorothy O’Neill, Jennifer Janik, Lynette Purdue, Deborah K. O’Connor, Christine Di Vita, Ian Frank
200666
17
Thalidomide for the Treatment of Esophageal Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection
The Journal of Infectious Diseases ·Jeffrey M. Jacobson, John Spritzler, Lawrence K. Fox, John L. Fahey, J. Brooks Jackson, Miriam Chernoff, David A. Wohl, Albert W. Wu, Thomas M. Hooton, Beverly E. Sha, Cecilia M. Shikuma, Laurie A. MacPhail, David M. Simpson, Carol Braun Trapnell, Nesli Basgoz
199963
18
Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Benigno Rodríguez, David M. Asmuth, Roy M. Matining, John Spritzler, Jeffrey M. Jacobson, Robbie B. Mailliard, Xiao-Dong Li, Ana I. Martínez, Allan R. Tenorio, Franco Lori, Julianna Lisziewicz, Suria Yesmin, Charles R. Rinaldo, Richard B. Pollard
201350
19
Placebo-Controlled Trial of Cyclosporin-A in HIV-1 Disease: Implications for Solid Organ Transplantation
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Leonard H. Calabrese, Michael M. Lederman, John Spritzler, Robert W. Coombs, Lawrence Fox, Barbara Schock, Belinda Yen‐Lieberman, Ronald R. Johnson, Donna Mildvan, Namita Parekh
200248
20
Interleukin‐2 Increases CD4+Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s
The Journal of Infectious Diseases ·Hernán Valdez, Ronald T. Mitsuyasu, Alan Landay, Anne Sevin, Ellen S. Chan, John Spritzler, Spyros A. Kalams, Richard B. Pollard, John L. Fahey, Lawrence Fox, Ann Namkung, Scharla Estep, Ronald B. Moss, David Sahner, Michael M. Lederman
200347

About John Spritzler

John Spritzler is a scholar working on Virology, Infectious Diseases, Epidemiology, Immunology and Emergency Medicine, having authored 55 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (37 papers), HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (14 papers), Immune Cell Function and Interaction (5 papers), Cytomegalovirus and herpesvirus research (5 papers), T-cell and B-cell Immunology (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV-related health complications and treatments (4 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (1.0k citations), Emergency Medicine (341 citations), Immunology (766 citations) and Epidemiology (723 citations). John Spritzler has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Alan Landay, Michael M. Lederman, Daniel R. Kuritzkes, Harold A. Kessler, Elizabeth Connick, Lawrence Fox, Richard B. Pollard, Jeffrey M. Jacobson, David M. Asmuth and Miriam Chernoff. Their work appears in journals such as The Journal of Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS, AIDS Research and Human Retroviruses and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P T SchellekensBreakdown of academic impact, for papers by Alessandro SiniccoBreakdown of academic impact, for papers by Hao WuBreakdown of academic impact, for papers by Deborah K. McMahonBreakdown of academic impact, for papers by Jason D. BarbourBreakdown of academic impact, for papers by M. DietrichBreakdown of academic impact, for papers by Maurice R.G. O’GormanBreakdown of academic impact, for papers by Clyde S. CrumpackerBreakdown of academic impact, for papers by Patricia Barditch‐CrovoBreakdown of academic impact, for papers by C. McLaren